These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 16757415)
21. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
26. Phaeohyphomycosis in a tertiary care cancer center. Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655 [TBL] [Abstract][Full Text] [Related]
27. Invasive fungal infections in children with hematologic and malignant diseases. Ozsevik SN; Sensoy G; Karli A; Albayrak C; Dagdemir A; Belet N; Elli M; Fisgin T; Ozyurek E; Duru F; Albayrak D J Pediatr Hematol Oncol; 2015 Mar; 37(2):e69-72. PubMed ID: 25072372 [TBL] [Abstract][Full Text] [Related]
28. Surveillance of infectious complications in hemato-oncological patients. Ram R; Gafter-Gvili A; Raanani P; Yeshurun M; Shpilberg O; Dreyer J; Peck A; Leibovici L; Paul M Isr Med Assoc J; 2009 Mar; 11(3):133-7. PubMed ID: 19544700 [TBL] [Abstract][Full Text] [Related]
29. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Boersma WG; Erjavec Z; van der Werf TS; de Vries-Hosper HG; Gouw AS; Manson WL Respir Med; 2007 Feb; 101(2):317-25. PubMed ID: 16774815 [TBL] [Abstract][Full Text] [Related]
30. [Analysis of risk factors of patients with chronic liver failure complicated invasive fungal infections]. Hu YR; Hu AR Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):214-7. PubMed ID: 20104782 [TBL] [Abstract][Full Text] [Related]
31. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Torres HA; Bodey GP; Rolston KV; Kantarjian HM; Raad II; Kontoyiannis DP Cancer; 2003 Jul; 98(1):86-93. PubMed ID: 12833460 [TBL] [Abstract][Full Text] [Related]
35. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149 [TBL] [Abstract][Full Text] [Related]
36. Microbiologic consequences of new approaches to managing hematologic malignancies. Blijlevens NM; Donnelly JP; de Pauw BE Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116 [TBL] [Abstract][Full Text] [Related]
37. Considerations in the approach to invasive fungal infection in patients with haematological malignancies. Bow EJ Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752 [TBL] [Abstract][Full Text] [Related]
38. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Granell M; Urbano-Ispizua A; Suarez B; Rovira M; Fernández-Avilés F; Martínez C; Ortega M; Uriburu C; Gaya A; Roncero JM; Navarro A; Carreras E; Mensa J; Vives J; Rozman C; Montserrat E; Lozano F Exp Hematol; 2006 Oct; 34(10):1435-41. PubMed ID: 16982337 [TBL] [Abstract][Full Text] [Related]
39. Mucormycosis-associated fungal infections in patients with haematologic malignancies. Kara IO; Tasova Y; Uguz A; Sahin B Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Camps IR Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]